Misplaced Pages

Revision as of 16:15, 23 August 2011

Post-traumatic stress disorder
Specialty	Psychiatry, clinical psychology

Posttraumatic stress disorder (also known as post-traumatic stress disorder or PTSD) is a severe anxiety disorder that can develop after exposure to any event that results in psychological trauma. This event may involve the threat of death to oneself or to someone else, or to one's own or someone else's physical, sexual, or psychological integrity, overwhelming the individual's ability to cope. As an effect of psychological trauma, PTSD is less frequent and more enduring than the more commonly seen acute stress response.

Diagnostic symptoms for PTSD include re-experiencing the original trauma(s) through flashbacks or nightmares, avoidance of stimuli associated with the trauma, and increased arousal – such as difficulty falling or staying asleep, anger, and hypervigilance. Formal diagnostic criteria (both DSM-IV-TR and ICD-10) require that the symptoms last more than one month and cause significant impairment in social, occupational, or other important areas of functioning.

Classification

Posttraumatic stress disorder is classified as an anxiety disorder, characterized by aversive anxiety-related experiences, behaviors, and physiological responses that develop after exposure to a psychologically traumatic event (sometimes months after). Its features persist for longer than 30 days, which distinguishes it from the briefer acute stress disorder. These persisting posttraumatic stress symptoms cause significant disruptions of one or more important areas of life function. It has three sub-forms: acute, chronic, and delayed-onset.

Causes

Psychological trauma

PTSD is believed to be caused by either physical trauma or psychological trauma, or more frequently a combination of both. According to Atkinson et al. (2000) PTSD is more likely to be caused by physical or psychological trauma caused by humans such as rape, war, or terrorist attack than trauma caused by natural disasters. Possible sources of trauma include experiencing or witnessing childhood or adult physical, emotional or sexual abuse. In addition, experiencing or witnessing an event perceived as life-threatening such as physical assault, adult experiences of sexual assault, accidents, drug addiction, illnesses, medical complications, or employment in occupations exposed to war (such as soldiers) or disaster (such as emergency service workers).

Traumatic events that may cause PTSD symptoms to develop include violent assault, kidnapping, sexual assault, torture, being a hostage, prisoner of war or concentration camp victim, experiencing a disaster, violent automobile accidents or getting a diagnosis of a life-threatening illness. Children or adults may develop PTSD symptoms by experiencing bullying or mobbing. Preliminary research suggests that child abuse may interact with mutations in a stress-related gene to increase the risk of PTSD in adults.

Multiple studies show that parental PTSD and other posttraumatic disturbances in parental psychological functioning can, despite a traumatized parent's best efforts, interfere with their response to their child as well as their child's response to trauma. Parents with violence-related PTSD may, for example, inadvertently expose their children to developmentally inappropriate violent media due to their need to manage their own emotional dysregulation. Clinical findings indicate that a failure to provide adequate treatment to children after they suffer a traumatic experience, depending on their vulnerability and the severity of the trauma, will ultimately lead to PTSD symptoms in adulthood.

Evolutionary psychology

Evolutionary psychology views different types of fears and reactions caused by fears as adaptations that may have been useful in the ancestral environment in order to avoid or cope with various threats. Mammals generally display several defensive behaviors roughly dependent on how close the threat is: avoidance, vigilant immobility, withdrawal, aggressive defense, appeasement, and finally complete frozen immobility (the last possible to confuse a predator's attack reflex or to simulate a dead and contaminated body). PTSD may correspond to and be caused by overactivation of such fear circuits. Thus, PTSD avoidance behaviors may correspond to mammal avoidance of and withdrawal from threats. Heightened memory of past threats may increase avoidance of similar situations in the future as well as be a prerequisite for analyzing the past threat and develop better defensive behaviors if the threat should reoccur. PTSD hyperarousal may correspond to vigilant immobility and aggressive defense. Complex post-traumatic stress disorder (and phenomena such as the Stockholm syndrome) may in part correspond to the appeasement stage and possibly the frozen immobility stage.

Neuroendocrinology

PTSD symptoms may result when a traumatic event causes an overactive adrenaline response, which creates deep neurological patterns in the brain. These patterns can persist long after the event that triggered the fear, making an individual hyper-responsive to future fearful situations.

PTSD displays biochemical changes in the brain and body that differ from other psychiatric disorders such as major depression. Individuals diagnosed with PTSD respond more strongly to a dexamethasone suppression test than individuals diagnosed with clinical depression.

In addition, most people with PTSD also show a low secretion of cortisol and high secretion of catecholamines in urine, with a norepinephrine/cortisol ratio consequently higher than comparable non-diagnosed individuals. This is in contrast to the normative fight-or-flight response, in which both catecholamine and cortisol levels are elevated after exposure to a stressor.

Brain catecholamine levels are low, and corticotropin-releasing factor (CRF) concentrations are high. Together, these findings suggest abnormality in the hypothalamic-pituitary-adrenal (HPA) axis.

Given the strong cortisol suppression to dexamethasone in PTSD, HPA axis abnormalities are likely predicated on strong negative feedback inhibition of cortisol, itself likely due to an increased sensitivity of glucocorticoid receptors. Some researchers have associated the response to stress in PTSD with long-term exposure to high levels of norepinephrine and low levels of cortisol, a pattern associated with improved learning in animals.

Translating this reaction to human conditions gives a pathophysiological explanation for PTSD by a maladaptive learning pathway to fear response through a hypersensitive, hyperreactive and hyperresponsive HPA axis.

Low cortisol levels may predispose individuals to PTSD: Following war trauma, Swedish soldiers serving in Bosnia and Herzegovina with low pre-service salivary cortisol levels had a higher risk of reacting with PTSD symptoms, following war trauma, than soldiers with normal pre-service levels. Because cortisol is normally important in restoring homeostasis after the stress response, it is thought that trauma survivors with low cortisol experience a poorly contained—that is, longer and more distressing—response, setting the stage for PTSD.

However, there is considerable controversy within the medical community regarding the neurobiology of PTSD. A review of existing studies on this subject showed no clear relationship between cortisol levels and PTSD. Only a slight majority have found a decrease in cortisol levels while others have found no effect or even an increase.

Neuroanatomy

Three areas of the brain whose function may be altered in PTSD have been identified: the prefrontal cortex, amygdala and hippocampus. Much of this research has utilised PTSD victims from the Vietnam War. For example, a prospective study using the Vietnam Head Injury Study showed that damage to the prefrontal cortex may actually be protective against later development of PTSD. In a study by Gurvits et al., combat veterans of the Vietnam War with PTSD showed a 20% reduction in the volume of their hippocampus compared with veterans who suffered no such symptoms. This finding could not be replicated in chronic PTSD patients traumatized at an air show plane crash in 1988 (Ramstein, Germany).

In human studies, the amygdala has been shown to be strongly involved in the formation of emotional memories, especially fear-related memories. Neuroimaging studies in humans have revealed both morphological and functional aspects of PTSD.

The amygdalocentric model of PTSD proposes that it is associated with hyperarousal of the amygdala and insufficient top-down control by the medial prefrontal cortex and the hippocampus particularly during extinction. This is consistent with an interpretation of PTSD as a syndrome of deficient extinction ability. Further animal and clinical research into the amygdala and fear conditioning may suggest additional treatments for the condition.

Genetics

There is evidence that susceptibility to PTSD is hereditary. For twin pairs exposed to combat in Vietnam, having a monozygotic (identical) twin with PTSD was associated with an increased risk of the co-twin having PTSD compared to twins that were dizygotic (non-identical twins).

Recently, it has been found that several single-nucleotide polymorphisms (SNPs) in FK506 binding protein 5 (FKBP5) interact with childhood trauma to predict severity of adult PTSD. These findings suggest that individuals with these SNPs who are abused as children are more susceptible to PTSD as adults.

This is particularly interesting given that FKBP5 SNPs have previously been associated with peritraumatic dissociation (that is, dissociation at the time of the trauma), which has itself been shown to be predictive of PTSD. Furthermore, FKBP5 may be less expressed in those with current PTSD. Another recent study found a single SNP in a putative estrogen response element on ADCYAP1R1 (encodes pituitary adenylate cyclase-activating polypeptide type I receptor or PAC1) to predict PTSD diagnosis and symptoms in females. Incidentally, this SNP is also associated with fear discrimination. The study suggests that perturbations in the PACAP-PAC1 pathway are involved in abnormal stress responses underlying PTSD.

Risk factors

Although most people (50-90%) encounter trauma over a lifetime, only about 8% develop full PTSD. Vulnerability to PTSD presumably stems from an interaction of biological diathesis, early childhood developmental experiences, and trauma severity.

Predictor models have consistently found that childhood trauma, chronic adversity, and familial stressors increase risk for PTSD as well as risk for biological markers of risk for PTSD after a traumatic event in adulthood. This effect of childhood trauma, which is not well understood, may be a marker for both traumatic experiences and attachment problems. Proximity to, duration of, and severity of the trauma also make an impact; and interpersonal traumas cause more problems than impersonal ones.

Military experience

Schnurr, Lunney, and Sengupta identified risk factors for the development of PTSD in Vietnam veterans. Among those are:

• Hispanic ethnicity, coming from an unstable family, being punished severely during childhood, childhood asocial behavior and depression as pre-military factors
• War-zone exposure, peritraumatic dissociation, depression as military factors
• Recent stressful life events, post-Vietnam trauma and depression as post-military factors

They also identified certain protective factors, such as:

• Japanese-American ethnicity, high school degree or college education, older age at entry to war, higher socioeconomic status and a more positive paternal relationship as pre-military protective factors
• Social support at homecoming and current social support as post-military factors. Other research also indicates the protective effects of social support in averting PTSD or facilitating recovery if it develops.

There may also be an attitudinal component; for example, a soldier who believes that they will not sustain injuries may be more likely to develop symptoms of PTSD than one who anticipates the possibility, should either be wounded. Likewise, the later incidence of suicide among those injured in home fires above those injured in fires in the workplace suggests this possibility.

Foster care

In the Casey Family Northwest Alumni Study, conducted in conjunction with researchers from the Harvard Medical School in Oregon and Washington state, the rate of PTSD in adults who were in foster care for one year between the ages of 14-18 was found to be higher than that of combat veterans. Up to 25 percent of those in the study meet the diagnostic criteria for PTSD as compared to 12-13 percent of Iraq war veterans and 15 percent of Vietnam War veterans, and a rate of 4 percent in the general population. The recovery rate for foster home alumni was 28.2% as opposed to 47% in the general population.

In one study (Dubner and Motta, 1999), 60% of children in foster care who had experienced sexual abuse had PTSD, and 42% of those who had been physically abused fulfilled the PTSD criteria. PTSD was also found in 18% of the children who were not abused. These children may have developed PTSD due to witnessing violence in the home, or as a result of real or perceived parental abandonment.

Diagnosis

Criteria

The diagnostic criteria for PTSD, stipulated in the Diagnostic and Statistical Manual of Mental Disorders IV (Text Revision) (DSM-IV-TR), may be summarized as:

A: Exposure to a traumatic event

This must have involved both (a) loss of "physical integrity", or risk of serious injury or death, to self or others, and (b) a response to the event that involved intense fear, horror or helplessness (or in children, the response must involve disorganized or agitated behavior). (The DSM-IV-TR criterion differs substantially from the previous DSM-III-R stressor criterion, which specified the traumatic event should be of a type that would cause "significant symptoms of distress in almost anyone," and that the event was "outside the range of usual human experience.")

B: Persistent re-experiencing

One or more of these must be present in the victim: flashback memories, recurring distressing dreams, subjective re-experiencing of the traumatic event(s), or intense negative psychological or physiological response to any objective or subjective reminder of the traumatic event(s).

C: Persistent avoidance and emotional numbing

This involves a sufficient level of:

• avoidance of stimuli associated with the trauma, such as certain thoughts or feelings, or talking about the event(s);
• avoidance of behaviors, places, or people that might lead to distressing memories;
• inability to recall major parts of the trauma(s), or decreased involvement in significant life activities;
• decreased capacity (down to complete inability) to feel certain feelings;
• an expectation that one's future will be somehow constrained in ways not normal to other people.

D: Persistent symptoms of increased arousal not present before

These are all physiological response issues, such as difficulty falling or staying asleep, or problems with anger, concentration, or hypervigilance.

E: Duration of symptoms for more than 1 month

If all other criteria are present, but 30 days have not elapsed, the individual is diagnosed with Acute stress disorder.

F: Significant impairment

The symptoms reported must lead to "clinically significant distress or impairment" of major domains of life activity, such as social relations, occupational activities, or other "important areas of functioning".

Assessment

Since the introduction of DSM-IV, the number of possible events which might be used to diagnose PTSD has increased; one study suggests that the increase is around 50%. Various scales exist to measure the severity and frequency of PTSD symptoms. Standardized screening tools such as Trauma Screening Questionnaire and PTSD Symptom Scale can be used to detect possible symptoms of posttraumatic stress disorder, and suggest the need for a formal diagnostic assessment.

Research-based alternative symptom groups

Emerging factor analytic research suggests that PTSD symptoms group empirically into four clusters, not the three currently described in the Diagnostic and Statistical Manual of Mental Disorders. One model supported by this research divides the traditional avoidance symptoms into a cluster of numbing symptoms (such as loss of interest and feeling emotionally numb) and a cluster of behavioral avoidance symptoms (such as avoiding reminders of the trauma). An alternative model adds a fourth cluster of dysphoric symptoms. These include symptoms of emotional numbing, as well as anger, sleep disturbance, and difficulty concentrating (traditionally grouped under the hyperarousal cluster).

DSM-5 proposed diagnostic criteria changes

In preparation for the May 2013 release of the DSM-5, the fifth version of the American Psychiatric Association's diagnostic manual, draft diagnostic criteria was released for public comment, followed by a two-year period of field testing. Proposed changes to the criteria include:

• Criterion A (prior exposure to traumatic events) is more specifically stated, and evaluation of an individual's emotional response at the time (current criterion A2) is dropped.
• Several items in Criterion B (intrusion symptoms) are rewritten to add or augment certain distinctions now considered important.
• Special consideration is given to developmentally appropriate criteria for use with children and adolescents. This is especially evident in the restated Criterion B - intrusion symptoms. Development of age-specific criteria for diagnosis of PTSD is ongoing at this time.
• Criterion C (avoidance and numbing) has been split into "C" and "D":
  • Criterion C (new version) now focuses solely on avoidance of behaviors or physical or temporal reminders of the traumatic experience(s). What were formerly two symptoms are now three, due to slight changes in descriptions.
  • New Criterion D focuses on negative alterations in cognition and mood associated with the traumatic event(s), and contains two new symptoms, one expanded symptom, and four largely unchanged symptoms specified in the previous criteria.
• Criterion E (formerly "D"), which focuses on increased arousal and reactivity, contains one modestly revised, one entirely new, and four unchanged symptoms.
• Criterion F (formerly "E") still requires duration of symptoms to have been at least one month.
• Criterion G (formerly "F") stipulates symptom impact ("disturbance") in the same way as before.
• The "acute" vs "delayed" distinction is dropped; the "delayed" specifier is considered appropriate if clinical symptom onset is no sooner than 6 months after the traumatic event(s).

"Developmental trauma disorder", a proposed new diagnosis, was still under discussion at the time of the draft publication.

Public policy response

In recent history, catastrophes (by human means or not) such as the 2004 Indian Ocean tsunami may have caused PTSD in many survivors and rescue workers. Today relief workers from organizations such as the Red Cross and the Salvation Army provide counseling after major disasters as part of their standard procedures to curb severe cases of posttraumatic stress disorder.

United States

A review of the provision of compensation to veterans for PTSD by the United States Department of Veterans Affairs began in 2005 after the VA had noted a 30% increase in PTSD claims in recent years. This led to a backlash from veterans'-rights groups, and to some highly publicized suicides by veterans who feared losing their benefits, which in some cases constituted their only income. In response, on November 10, 2005, the Secretary of Veterans Affairs announced that "the Department of Veterans Affairs (VA) will not review the files of 72,000 veterans currently receiving disability compensation for posttraumatic stress disorder..."

The diagnosis of PTSD in U.S. military veterans has been a subject of some controversy due to uncertainties in objectively diagnosing PTSD in those who may have been exposed to trauma, and due to this diagnosis' association with some incidence of compensation-seeking behavior.

Many veterans of the wars in Iraq and Afghanistan returning home have faced significant physical, emotional and relational disruptions. In response, the United States Marine Corps has instituted programs to assist them in re-adjusting to civilian life, especially in their relationships with spouses and loved ones, to help them communicate better and understand what the other has gone through. Walter Reed Army Institute of Research (WRAIR) developed the Battlemind program to assist service members avoid or ameliorate PTSD and related problems.

Other countries

In the UK, there has been some controversy that National Health Service is dumping veterans on service charities like Combat Stress.

Veterans Affairs Canada offers a new program that includes rehabilitation, financial benefits, job placement, health benefits program, disability awards and family support.

Management

Prevention and early intervention strategies

Modest benefits have been seen from early access to cognitive behavioral therapy, as well as from some medications such as propranolol. Critical incident stress management has been suggested as a means of preventing PTSD but subsequent studies suggest the likelihood of its producing iatrogenic outcomes. A review of multiple studies confirmed the finding of no benefit to trauma survivors from single-session early-response interventions, as well as a failure of blanket multiple-session prevention interventions to yield a benefit to all participants (some were even harmed).

Early detection

The ability to prescreen individuals would be of great help in getting treatment to those who are at risk of PTSD prior to development of the syndrome. Several biological indicators have been identified that are related to later PTSD development. First, Delhanty found that higher response times and a smaller hippocampal volume were identified as linked to later PTSD development. However, both of these indicators are relatively difficult to test for and need specialized tests and or equipment to identify. A blood biomarker is much easier to test for. Van Zuiden et al. found just such a biomarker when testing U.S. Army soldiers prior to deployment. They found that soldiers with more glucocorticoid receptors (GR) were more likely to be diagnosed with PTSD six months after deployment. However, higher GR levels have not been identified as a cause of PTSD, and may instead be an intermediator, or even an indicator that the individual has previously experienced traumatic events. There is a great deal of overlap between high GR levels and those who later are diagnosed with and without PTSD. Thus, the identification of high GR is simply a vulnerability indicator at this time.

Delhanty found that biological precursors existed directly following traumatic exposure in those who later developed chronic PTSD and were significantly different from those who did not. Directly following the traumatic event later sufferers often have significantly lower levels of hypothalamic pituitary-adrenal activity and a corresponding decrease in Cortisol. Other methods of early detection include the identification of specific risk factors associated with later PTSD symptoms. Resnick, Acierno, Holmes, Kilpatrick, and Jager for example were able to identify that the forensic exam given to victims after a rape was associated with PTSD. Finally, global treatments attempt to avoid the problems of early detection by simply treating everyone involved. However, many studies have found this to be often ineffective and for global treatments to at times increase prevalence rates of PTSD.

Preventive Treatments

Psychological debriefing

The first form of preventive treatment is that of a psychological debriefing. Psychological debriefing is the most often used preventive measure. One of the main reasons for this is the relative ease with which this treatment can be given to individuals directly following an event. It consists of interviews that are meant to allow individuals to directly confront the event and share their feelings with the counselor and to help structure their memories of the event. However, while this form of therapy is the most often used it is actually the least effective. Studies have had mixed findings concerning psychological debriefings and have ranged from being of significant help to helping in the formation of PTSD in individuals who would otherwise have not developed PTSD. The greater number of studies tends to simply find that it is neither overly beneficial nor harmful.

Risk Targeted Interventions

Risk targeted interventions are those that attempt to mitigate specific formative information or events. It can target modeling normal behaviors, instruction on a task or giving information on the event. For example, rape victims were given an instruction video on the procedures for a forensic exam. Also included in the video was advice on how to identify and stop avoidance behavior and control anxiety. Finally, the individuals modeling the forensic exam were shown to be calm and relaxed. PTSD diagnosis for those who saw the video were thirty three percent less than for those who went through the standard forensic procedure.

Psychobiological Treatments

Psychobiological treatments have also found success, especially with cortisol. Psychobiological treatments target biological changes that occur after a traumatic event. They also attempt to chemically alter learning or memory formation. Cortisol treatments after a traumatic event have found success in mitigating later diagnosis of PTSD. As discussed earlier Cortisol is often lower in individuals who are at risk of PTSD after a traumatic event than their counterparts. By increasing cortisol levels to normal levels this has been shown to reduce arousal post event as well prevent GR upregulation.

Stepped Collaborative Care

Stepped collaborative care is where individuals who are at risk are monitored for symptoms. As symptoms of PTSD appear the level of care is increased to treat those symptoms.

Psychotherapeutic interventions

Many forms of psychotherapy have been advocated for trauma-related problems such as PTSD. Basic counseling practices common to many treatment responses for PTSD include education about the condition and provision of safety and support.

The psychotherapy programs with the strongest demonstrated efficacy include cognitive behavioral programs, variants of exposure therapy, stress inoculation training (SIT), variants of cognitive therapy (CT), eye movement desensitization and reprocessing (EMDR), and many combinations of these procedures. A 2010 review disagrees that these treatments have proven efficacy, and points out methodological flaws in the studies and previous meta-analyses.

EMDR or trauma-focused cognitive behavioral therapy (TFCBT) was recommended as first-line treatments for trauma victims in a 2007 review; however, "the evidence base was not as strong as that for TFCBT ... Furthermore, there was limited evidence that TFCBT and EMDR were superior to supportive/non-directive treatments, hence it is highly unlikely that their effectiveness is due to non-specific factors such as attention." A meta-analytic comparison of EMDR and cognitive behavioral therapy found both protocols indistinguishable in terms of effectiveness in treating PTSD; however "the contribution of the eye movement component in EMDR to treatment outcome" is unclear.

Behavioral and Cognitive Behavioral therapy

Cognitive Behavioral Therapy (CBT) seeks to change the way a trauma victim feels and acts by changing the patterns of thinking and/or behavior responsible for negative emotions. CBT have been proven to be an effective treatment for PTSD, and is currently considered the standard of care for PTSD by the United States Department of Defense In CBT, individuals learn to identify thoughts that make them feel afraid or upset, and replace them with less distressing thoughts. The goal is to understand how certain thoughts about cause PTSD-related stress.

Recent research on contextually based third-generation behavior therapies suggests that they may produce results comparable to some of the better validated therapies. Many of these therapy methods have a significant element of exposure, and have demonstrated success in treating the primary problems of PTSD and co-occurring depressive symptoms.

Exposure therapy is a type of cognitive behavioral therapy that involves assisting trauma survivors to re-experience distressing trauma-related memories and reminders in order to facilitate habituation and successful emotional processing of the trauma memory. Most exposure therapy programs include both imaginal confrontation with the traumatic memories and real-life exposure to trauma reminders; this therapy modality is well supported by clinical evidence. Indeed, the success of exposure-based therapies has raised the question of whether exposure is a necessary ingredient in the treatment of PTSD. Some organizations have endorsed the need for exposure. The US Department of Veterans Affairs has been actively training mental health treatment staff in Prolonged Exposure Therapy and Cognitive Processing Therapy in an effort to better treat US Veterans with PTSD.

Eye movement desensitization and reprocessing

Eye movement desensitization and reprocessing (EMDR) is specifically targeted as a treatment for PTSD. Based on the evidence of controlled research, the American Psychiatric Association and the United States Department of Veterans Affairs and Department of Defense have placed EMDR in the highest category of effectiveness and research support in the treatment of trauma. Several international bodies have made similar recommendations. However, some reviewers no longer believe that the eye movements assist in recovery, proposing instead that the review of and engagement with memories, processing of cognitions, and rehearsal of coping skills are the psychotherapeutically effective components of the procedure.

Interpersonal psychotherapy

Other approaches, particularly involving social supports, may also be important. An open trial of interpersonal psychotherapy reported high rates of remission from PTSD symptoms without using exposure. A current, NIMH-funded trial in New York City is now (and into 2013) comparing interpersonal psychotherapy, prolonged exposure therapy, and relaxation therapy.

Medication

A variety of medications has shown adjunctive benefit in reducing PTSD symptoms, but "there is no clear drug treatment for PTSD". Positive symptoms (re-experiencing, hypervigilance, increased arousal) generally respond better to medication than negative symptoms (avoidance, withdrawal), and it is recommended that any drug trial last for at least 6–8 weeks.

Symptom management: potentially useful medication classes

SSRIs (selective serotonin reuptake inhibitors). SSRIs are considered to be a first-line drug treatment. SSRIs for which there are data to support use include: citalopram, escitalopram, fluoxetine, fluvoxamine, paroxetine, and sertraline.

Among the anti-depressants described in this section, bupropion and venlafaxine have the lowest patient drop-out rates. Sertraline, fluoxetine, and nefazodone have a modestly higher drop-out rate (~15%), and the heterocyclics and paroxetine have the highest rates (~20%+). Where drop-out is caused or feared because of medication side-effects, it should be remembered that most patients do not experience such side-effects.

Alpha-adrenergic antagonists. Prazosin ("Minipress"), in a small study of combat veterans, has shown substantial benefit in relieving or reducing nightmares. Clonidine ("Catapres") can be helpful with startle, hyperarousal, and general autonomic hyperexcitability.

Anti-convulsants, mood stabilizers, anti-aggression agents. Carbamazepine ("Tegretol") has likely benefit in reducing arousal symptoms involving noxious affect, as well as mood or aggression. Topiramate ("Topamax") has been effective in achieving major reductions in flashbacks and nightmares, and no reduction of effect was seen over time. Zolpidem ("Ambien") has also proven useful in treating sleep disturbances.

Lamotrigine ("Lamictal") may be useful in reducing reexperiencing symptoms, as well as avoidance and emotional numbing. Valproic acid ("Depakene") and has shown reduction of symptoms of irritability, aggression, and impulsiveness, and in reducing flashbacks. Similarly, lithium carbonate has worked to control mood and aggressions (but not anxiety) symptoms. Buspirone ("BuSpar") has an effect similar to that of lithium, with the additional benefit of working to reduce hyperarousal symptoms.

Antipsychotics. Risperidone can be used to help with dissociation, mood issues, and aggression.

Atypical antidepressants. Nefazodone ("Serzone") can be effective with sleep disturbance symptoms, and with secondary depression, anxiety, and sexual dysfunction symptoms. Trazodone ("Desyrel") can also reduce or eliminate problems with disturbed sleep, and with anger and anxiety.

Beta blockers. Propranolol ("Inderal") has demonstrated possibilities in reducing hyperarousal symptoms, including sleep disturbances.

Benzodiazepines. These can be used with caution for short-term anxiety relief, hyperarousal, and sleep disturbance. While benzodiazepines can alleviate acute anxiety, there is no consistent evidence that they can stop the development of PTSD, or are at all effective in the treatment of posttraumatic stress disorder. Additionally benzodiazepines may reduce the effectiveness of psychotherapeutic interventions and there is some evidence that benzodiazepines may contribute to the development and chronification of PTSD. Other drawbacks include the risk of developing a benzodiazepine dependence and withdrawal syndrome; additionally individuals with PTSD are at an increased risk of abusing benzodiazepines.

Glucocorticoids. Additionally, post-stress high dose corticosterone administration was recently found to reduce 'PTSD-like' behaviors in a rat model of PTSD. In this study, corticosterone impaired memory performance, suggesting that it may reduce risk for PTSD by interfering with consolidation of traumatic memories. The neurodegenerative effects of the glucocorticoids, however, may prove this treatment counterproductive.

Heterocyclic / Tricyclic anti-depressants anti-depressants. Amitriptyline ("Elavil") has shown benefit for positive distress symptoms, and for avoidance, and Imipramine ("Tofranil") has shown benefit for intrusive symptoms.

Monoamine-oxidase inhibitors (MAOs). Phenelzine ("Nardil") has for some time been observed to be effective with hyperarousal and depression, and is especially effective with nightmares.

Miscellaneous other medications. Clinical trials evaluating methylenedioxymethamphetamine (MDMA, "Ecstasy") in conjunction with psychotherapy are being conducted in Switzerland and Israel.

Symptom prevention: potentially useful medication classes

Some medications have shown benefit in preventing PTSD or reducing its incidence, when given in close proximity to a traumatic event. These medications include:

Alpha-adrenergic antagonists. Anecdotal report of success in using clonidine ("Catapres") to reduce traumatic stress symptoms suggests that it may have benefit in preventing PTSD.

Beta blockers. Propranolol ("Inderal"), similarly to clonidine, may be useful if there are significant symptoms of "over-arousal". These may inhibit the formation of traumatic memories by blocking adrenaline's effects on the amygdala.

Glucocorticoids. There is some evidence suggesting that administering glucocorticoids immediately after a traumatic experience may help prevent PTSD. Several studies have shown that individuals who receive high doses of hydrocortisone for treatment of septic shock, or following surgery, have a lower incidence and fewer symptoms of PTSD.

Opiates. In a retrospective analysis of combat injury field data for US troops in Iraq, it was found that those who received morphine in the early stages of their treatment had a significantly lower rate of subsequent PTSD, when compared with those who did not receive morphine at that time.

Medications by symptom group affected

Medications can affect one or more of the symptoms, in one or more of the three major symptom classes involved in diagnosing PTSD, which can be summarized in the following table:

Some medications can also help with symptoms which may occur secondary to PTSD.

Medication and self-medication issues and risks with PTSD

Alcohol abuse and drug abuse commonly co-occur with PTSD. Recovery from posttraumatic stress disorder or other anxiety disorders may be hindered, or the condition worsened, by medication or substance overuse, abuse, or dependence; resolving these problems can bring about a marked improvement in an individual's mental health status and anxiety levels.

Benzodiazepines are risky in several ways. They can be especially addictive when PTSD is present, and this is especially true with the fast-acting ones. Dis-inhibition upon initiation of treatment is another risk with this medication class. Finally, termination of the drug can be especially difficult. Recovery from benzodiazepine abuse or dependence tends to take a lot longer than recovery from alcohol abuse or dependence, but people can regain their previous good health. PTSD symptoms may temporarily worsen however, during alcohol withdrawal or benzodiazepine withdrawal.

Yohimbine (not considered specifically appropriate for PTSD) increases arousal by increasing release of endogenous norepinephrine, and can worsen PTSD symptoms.

Epidemiology

There is debate over the rates of PTSD found in populations, but despite changes in diagnosis and the criteria used to define PTSD between 1997 and 2007, epidemiological rates have not changed significantly.

International PTSD rates

The United Nations' World Health Organization publishes estimates of PTSD impact for each of its member states; the latest data available are for 2004. Considering only the 25 most populated countries, ranked by overall age-standardized Disability-Adjusted Life Year (DALY) rate, the top half of the ranked list is dominated by Asian/Pacific countries, the USA, and Egypt. Ranking the countries by the male-only or female-only rates produces much the same result, but with less meaningfulness, as the score range in the single sex rankings is much reduced (4 for women, 3 for men, as compared with 14 for the overall score range), suggesting that the differences between female and male rates, within each country, is what drives the distinctions between the countries.

United States

The National Comorbidity Survey has estimated that the lifetime prevalence of PTSD among adult Americans is 7.8%, with women (10.4%) twice as likely as men (5%) to have PTSD at some point in their lives.

The United States Department of Veterans Affairs estimates that 830,000 Vietnam War veterans suffered symptoms of PTSD. The National Vietnam Veterans' Readjustment Study (NVVRS) found 15.2% of male and 8.5% of female Vietnam Vets to suffer from current PTSD at the time of the study. Life-Time prevalence of PTSD was 30.9% for males and 26.9% for females. In a reanalysis of the NVVRS data, along with analysis of the data from the Matsunaga Vietnam Veterans Project, Schnurr, Lunney, Sengupta, and Waelde found that, contrary to the initial analysis of the NVVRS data, a large majority of Vietnam veterans suffered from PTSD symptoms (but not the disorder itself). Four out of five reported recent symptoms when interviewed 20–25 years after Vietnam.

Further reading: Benefits for US Veterans with PTSD

In other species

There have been reports of captive and wild elephants suffering from posttraumatic stress reactions, the latter from seeing members of their herd shot by hunters. Service dogs used overseas in the military have been said to develop posttraumatic stress after witnessing war.

History

Earliest reports

Reports of battle-associated stress reactions appear as early as the 6th century BC/BCE. One of the first descriptions of PTSD was made by the Greek historian Herodotus. In 490 BC/BCE he described, during the Battle of Marathon, an Athenian soldier who suffered no injury from war but became permanently blind after witnessing the death of a fellow soldier.

Modern recognition in military settings

In the early 19th century military medical doctors started diagnosing soldiers with "exhaustion" after the stress of battle. This "exhaustion" was characterized by mental shutdown due to individual or group trauma. Soldiers during the 19th century were not supposed to be scared or show any fear in the midst of battle. The only treatment for this "exhaustion" was to bring the afflicted to the back for a bit then send them back into battle. During the intense and frequently repeated stress, the soldiers became fatigued as a part of their body's natural shock reaction.

According to Stéphane Audoin-Rouzeau and Annette Becker, "One-tenth of mobilized American men were hospitalized for mental disturbances between 1942 and 1945, and after thirty-five days of uninterrupted combat, 98% of them manifested psychiatric disturbances in varying degrees."

Although PTSD-like symptoms have also been recognized in combat veterans of many military conflicts since, the modern understanding of PTSD dates from the 1970s, largely as a result of the problems that were still being experienced by US military veterans of the war in Vietnam.

Previous diagnoses now considered historical equivalents of PTSD include railway spine, stress syndrome, shell shock, battle fatigue, or traumatic war neurosis.

Terminology

The term post-traumatic stress disorder (PTSD) was coined in the mid 1970s, in part through the efforts of anti-Vietnam War activists and the anti war group Vietnam Veterans Against the War and Chaim F. Shatan, who worked with them and coined the term post-Vietnam Syndrome; the condition was added to the DSM-III as posttraumatic stress disorder.

Early in 1978, the term was used in a working group finding presented to the Committee of Reactive Disorders. The term was formally recognized in 1980. (In the authoritative DSM-IV, the spelling "posttraumatic stress disorder" is used. Elsewhere, "posttraumatic" is often rendered as two words — "post-traumatic stress disorder" or "post traumatic stress disorder" — especially in less formal writing on the subject.)

See also

References

1. ^ American Psychiatric Association (1994). Diagnostic and statistical manual of mental disorders: DSM-IV. Washington, DC: American Psychiatric Association. ISBN 0890420610. Cite error: The named reference "DSM4" was defined multiple times with different content (see the help page).
2. Satcher D; et al. (1999). "Chapter 4.2". Mental Health: A Report of the Surgeon General. Surgeon General of the United States. {{cite book}}: Explicit use of et al. in: |author= (help)
3. ^ Brunet A, Akerib V, Birmes P (2007). "Don't throw out the baby with the bathwater (PTSD is not overdiagnosed)" (PDF). Can J Psychiatry. 52 (8): 501–2, discussion 503. PMID 17955912. Retrieved 2008-03-12.{{cite journal}}: CS1 maint: multiple names: authors list (link)
4. Kaplan, HI (1994). Kaplan and Sadock's synopsis of psychiatry: Behavioral sciences, clinical psychiatry, 7th ed. Baltimore: Williams & Williams. pp. 606–609. {{cite book}}: Unknown parameter |coauthors= ignored (|author= suggested) (help)
5. Satcher D; et al. (1999). "Chapter 4". Mental Health: A Report of the Surgeon General. Surgeon General of the United States. {{cite book}}: Explicit use of et al. in: |author= (help)
6. Fullerton, CS (2004). "Acute Stress Disorder, Posttraumatic Stress Disorder, and Depression in Disaster or Rescue Workers". Am J Psychiatry. 161: 1370–1376. {{cite journal}}: Unknown parameter |coauthors= ignored (|author= suggested) (help)
7. Kelleher I, Harley M, Lynch F, Arseneault L, Fitzpatrick C, Cannon M (2008). "Associations between childhood trauma, bullying and psychotic symptoms among a school-based adolescent sample". Br J Psychiatry. 193 (5): 378–82. doi:10.1192/bjp.bp.108.049536. PMID 18978317. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
8. Current Psychiatry Volume 8 Number 4
9. Binder EB, Bradley RG, Liu W; et al. (2008). "Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults". JAMA. 299 (11): 1291–305. doi:10.1001/jama.299.11.1291. PMC 2441757. PMID 18349090. {{cite journal}}: Explicit use of et al. in: |author= (help); Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
10. Peggy Peck, Executive Editor (2008-03-09). "Genes May Affect Lifelong Impact of Child Abuse". MedPage Today. {{cite news}}: |author= has generic name (help)
11. Constance Holden (2008-03-18). "Seeds of PTSD Planted in Childhood". ScienceNOW Daily News.
12. Schechter DS, Coates SW, Kaminer T; et al. (2008). "Distorted maternal mental representations and atypical behavior in a clinical sample of violence-exposed mothers and their toddlers". J Trauma Dissociation. 9 (2): 123–47. doi:10.1080/15299730802045666. PMC 2577290. PMID 18985165. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
13. Schechter DS, Zygmunt A, Coates SW; et al. (2007). "Caregiver traumatization adversely impacts young children's mental representations on the MacArthur Story Stem Battery". Attach Hum Dev. 9 (3): 187–205. doi:10.1080/14616730701453762. PMC 2078523. PMID 18007959. {{cite journal}}: Explicit use of et al. in: |author= (help); Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
14. Schechter DS, Gross A, Willheim E; et al. (2009). "Is maternal PTSD associated with greater exposure of very young children to violent media?". J Trauma Stress. 22 (6): 658–62. doi:10.1002/jts.20472. PMC 2798921. PMID 19924819. {{cite journal}}: Explicit use of et al. in: |author= (help); Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
15. Clarke, C. et. al. 2007. Childhood and Adulthood Psychological Ill Health as Predictors of Midlife and Anxiety disorders. Archives of General Psychiatry. 64. pp668-678
16. Chris Cantor (2005). Evolution and posttraumatic stress: disorders of vigilance and defence. Routledge. ISBN 978-1-58391-771-8.
17. cite doi|10.1080/00048670701261178}}
18. Attention: This template ({{cite doi}}) is deprecated. To cite the publication identified by doi:10.1016/j.pnpbp.2006.01.008, please use {{cite journal}} (if it was published in a bona fide academic journal, otherwise {{cite report}} with |doi=10.1016/j.pnpbp.2006.01.008 instead.
19. PBS Series "The Secret Life of the Brain Episode 4, 2001
20. Yehuda R, Halligan SL, Golier JA, Grossman R, Bierer LM (2004). "Effects of trauma exposure on the cortisol response to dexamethasone administration in PTSD and major depressive disorder". Psychoneuroendocrinology. 29 (3): 389–404. doi:10.1016/S0306-4530(03)00052-0. PMID 14644068.{{cite journal}}: CS1 maint: multiple names: authors list (link)
21. Yehuda R, Halligan SL, Grossman R, Golier JA, Wong C (2002). "The cortisol and glucocorticoid receptor response to low dose dexamethasone administration in aging combat veterans and holocaust survivors with and without posttraumatic stress disorder". Biol Psychiatry. 52 (5): 393–403. doi:10.1016/S0006-3223(02)01357-4. PMID 12242055.{{cite journal}}: CS1 maint: multiple names: authors list (link)
22. Mason JW, Giller EL, Kosten TR, Harkness L (1988). "Elevation of urinary norepinephrine/cortisol ratio in posttraumatic stress disorder". J Nerv Ment Dis. 176 (8): 498–502. doi:10.1097/00005053-198808000-00008. PMID 3404142.{{cite journal}}: CS1 maint: multiple names: authors list (link)
23. Bohnen N, Nicolson N, Sulon J, Jolles J (1991). "Coping style, trait anxiety and cortisol reactivity during mental stress". J Psychosom Res. 35 (2–3): 141–7. doi:10.1016/0022-3999(91)90068-Y. PMID 2046048.{{cite journal}}: CS1 maint: multiple names: authors list (link)
24. Geracioti TD Jr, Baker DG, Ekhator NN, West SA, Hill KK, Bruce AB, Schmidt D, Rounds-Kugler B, Yehuda R, Keck PE Jr, Kasckow JW (2001). "CSF norepinephrine concentrations in posttraumatic stress disorder". Am J Psychiatry. 158 (8): 1227–1230. doi:10.1176/appi.ajp.158.8.1227. PMID 11481155.{{cite journal}}: CS1 maint: multiple names: authors list (link)
25. Sautter FJ, Bissette G, Wiley J; et al. (2003). "Corticotropin-releasing factor in posttraumatic stress disorder (PTSD) with secondary psychotic symptoms, nonpsychotic PTSD, and healthy control subjects". Biol. Psychiatry. 54 (12): 1382–8. doi:10.1016/S0006-3223(03)00571-7. PMID 14675802. {{cite journal}}: Explicit use of et al. in: |author= (help); Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
26. de Kloet CS, Vermetten E, Geuze E; et al. (2008). "Elevated plasma corticotrophin-releasing hormone levels in veterans with posttraumatic stress disorder". Prog. Brain Res. 167: 287–91. doi:10.1016/S0079-6123(07)67025-3. PMID 18037027. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
27. Yehuda R (2001). "Biology of posttraumatic stress disorder". J Clin Psychiatry. 62. Suppl 17: 41–6. PMID 11495096.
28. Yehuda R (2002). "Clinical relevance of biologic findings in PTSD". Psychiatr Q. 73 (2): 123–33. doi:10.1023/A:1015055711424. PMID 12025720.
29. Aardal-Eriksson E, Eriksson TE, Thorell LH (2001). "Salivary cortisol, posttraumatic stress symptoms, and general health in the acute phase and during 9-month follow-up". Biol. Psychiatry. 50 (12): 986–93. doi:10.1016/S0006-3223(01)01253-7. PMID 11750895.{{cite journal}}: CS1 maint: multiple names: authors list (link)
30. Lindley SE, Carlson EB, Benoit M (2004). "Basal and dexamethasone suppressed salivary cortisol concentrations in a community sample of patients with posttraumatic stress disorder". Biol. Psychiatry. 55 (9): 940–5. doi:10.1016/j.biopsych.2003.12.021. PMID 15110738.{{cite journal}}: CS1 maint: multiple names: authors list (link)
31. "NIMH · Post Traumatic Stress Disorder Research Fact Sheet". National Institutes of Health.
32. Newton, Philip. "From Mouse to Man; the Anatomy of Posttraumatic Stress Disorder". Retrieved 20 December 2009. {{cite web}}: Check |authorlink= value (help); External link in |authorlink= (help)
33. Carlson, Neil R. (2007). Physiology of Behavior (9 ed.). Pearson Education, Inc.
34. Jatzko A, Rothenhöfer S, Schmitt A, Gaser C, Demiracka T, Weber-Fahr W, Wessa M, Magnotta V, Braus DF.; et al. (2006). "Hippocampal volume in chronic posttraumatic stress disorder (PTSD): MRI study using two different evaluation methods". Journal of Affective Disorders. 94 (1–3): 121–126. doi:10.1016/j.jad.2006.03.010. PMID 16701903. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
35. http://dbm.neuro.uni-jena.de/pdf-files/Jatzko-JAD06.pdf
36. ^ Milad MR, Pitman RK, Ellis CB, Gold AL, Shin LM, Lasko NB, Zeidan MA, Handwerger K, Orr SP; et al. (2009). "Neurobiological basis of failure to recall extinction memory in posttraumatic stress disorder". Biol Psychiatry. 66 (12): 1075–82. doi:10.1016/j.biopsych.2009.06.026. PMC 2787650. PMID 19748076. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
37. Stein MB, Paulus MP (2009). "Imbalance of approach and avoidance: the yin and yang of anxiety disorders". Biol Psychiatry. 66 (12): 1072–4. doi:10.1016/j.biopsych.2009.09.023. PMC 2825567. PMID 19944792.
38. True WR, Rice J, Eisen SA; et al. (1993). "A twin study of genetic and environmental contributions to liability for posttraumatic stress symptoms". Arch. Gen. Psychiatry. 50 (4): 257–64. PMID 8466386. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
39. http://www.psychologytoday.com/blog/mouse-man/200811/gene-anxiety-depression-and-posttraumatic-stress-disorder-fkbp5
40. Binder EB, Bradley RG, Liu W; et al. (2008). "Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults". JAMA. 299 (11): 1291–305. doi:10.1001/jama.299.11.1291. PMC 2441757. PMID 18349090. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
41. Koenen KC, Saxe G, Purcell S; et al. (2005). "Polymorphisms in FKBP5 are associated with peritraumatic dissociation in medically injured children". Mol Psychiatry. 10 (12): 1058–9. doi:10.1038/sj.mp.4001727. PMID 16088328. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
42. Birmes P, Brunet A, Carreras D; et al. (2003). "The predictive power of peritraumatic dissociation and acute stress symptoms for posttraumatic stress symptoms: a three-month prospective study". Am J Psychiatry. 160 (7): 1337–9. doi:10.1176/appi.ajp.160.7.1337. PMID 12832251. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
43. ^ Schnurr PP, Lunney CA, Sengupta A (2004). "Risk factors for the development versus maintenance of posttraumatic stress disorder". J Trauma Stress. 17 (2): 85–95. doi:10.1023/B:JOTS.0000022614.21794.f4. PMID 15141781.{{cite journal}}: CS1 maint: multiple names: authors list (link)
44. Yehuda R, Cai G, Golier JA, Sarapas C, Galea S, Ising M, Rein T, Schmeidler J, Müller-Myhsok B, Holsboer F, Buxbaum JD (24 April 2009 ). "Gene expression patterns associated with posttraumatic stress disorder following exposure to the World Trade Center attacks". Biol Psychiatry. 66 (7): 708–11. doi:10.1016/j.biopsych.2009.02.034. PMID 19393990. {{cite journal}}: Check date values in: |date= (help)CS1 maint: multiple names: authors list (link)
45. Ressler KJ, Merer KB, Bradley B; et al. (February 24, 2011). "Post-traumatic stress disdorder is associated with PACAP and the PAC1 receptor". Nature. 470 (7335): 492–497. doi:10.1038/nature09856. PMC 3046811. PMID 21350482. {{cite journal}}: Explicit use of et al. in: |author= (help); Unknown parameter |laydate= ignored (help); Unknown parameter |laysource= ignored (help); Unknown parameter |laysummary= ignored (help)CS1 maint: multiple names: authors list (link)
46. ^ Kessler RC, Sonnega A, Bromet E, Hughes M, Nelson CB (1995). "Posttraumatic stress disorder in the National Comorbidity Survey". Arch Gen Psychiatry. 52 (12): 1048–60. PMID 7492257. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
47. Breslau N, Kessler RC, Chilcoat HD, Schultz LR, Davis GC, Andreski P (1998). "Trauma and posttraumatic stress disorder in the community: the 1996 Detroit Area Survey of Trauma". Arch Gen Psychiatry. 55 (7): 626–32. doi:10.1001/archpsyc.55.7.626. PMID 9672053. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
48. Koenen KC, Moffitt TE, Poulton R, Martin J, Caspi A (2007). "Early childhood factors associated with the development of post-traumatic stress disorder: results from a longitudinal birth cohort". Psychol Med. 37 (2): 181–92. doi:10.1017/S0033291706009019. PMC 2254221. PMID 17052377. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
49. Lapp KG, Bosworth HB, Strauss JL; et al. (2005). "Lifetime sexual and physical victimization among male veterans with combat-related post-traumatic stress disorder". Mil Med. 170 (9): 787–90. PMID 16261985. {{cite journal}}: Explicit use of et al. in: |author= (help); Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
50. Otte C, Neylan TC, Pole N; et al. (2005). "Association between childhood trauma and catecholamine response to psychological stress in police academy recruits". Biol. Psychiatry. 57 (1): 27–32. doi:10.1016/j.biopsych.2004.10.009. PMID 15607297. {{cite journal}}: Explicit use of et al. in: |author= (help); Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
51. Resnick HS, Yehuda R, Pitman RK, Foy DW (1995). "Effect of previous trauma on acute plasma cortisol level following rape". Am J Psychiatry. 152 (11): 1675–7. PMID 7485635. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
52. Laor N, Wolmer L, Mayes LC; et al. (1996). "Israeli preschoolers under Scud missile attacks. A developmental perspective on risk-modifying factors". Arch Gen Psychiatry. 53 (5): 416–23. PMID 8624185. {{cite journal}}: Explicit use of et al. in: |author= (help); Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
53. Laor N, Wolmer L, Mayes LC, Gershon A, Weizman R, Cohen DJ (1997). "Israeli preschool children under Scuds: a 30-month follow-up". J Am Acad Child Adolesc Psychiatry. 36 (3): 349–56. doi:10.1097/00004583-199703000-00013. PMID 9055515. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
54. Janoff-Bulman R: Shattered Assumptions: Toward a New Psychology of Trauma. New York: Free Press, 1992.
55. ^ Jennifer L. Price, Ph.D.: Findings from the National Vietnam Veterans' Readjustment Study - Factsheet. National Center for PTSD. United States Department of Veterans Affairs .
56. ^ Brewin CR, Andrews B, Valentine JD (2000). "Meta-analysis of risk factors for posttraumatic stress disorder in trauma-exposed adults". J Consult Clin Psychol. 68 (5): 748–66. doi:10.1037/0022-006X.68.5.748. PMID 11068961. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
57. ^ Ozer EJ, Best SR, Lipsey TL, Weiss DS (2003). "Predictors of posttraumatic stress disorder and symptoms in adults: a meta-analysis". Psychol Bull. 129 (1): 52–73. doi:10.1037/0033-2909.129.1.52. PMID 12555794. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
58. "Former Foster Children in Oregon and Washington Suffer Posttraumatic Stress Disorder at Twice the Rate of U.S War Veterans" (PDF) (Press release). Casey Family Programs, Harvard Medical School. 2005.04.05. Retrieved 2010-03-23. {{cite press release}}: Check date values in: |date= (help)
59. Casey Family Programs (2005). "Assessing the Effects of Foster Care: Mental Health Outcomes from the Casey National Alumni Study" (PDF).
60. Dubner AE, Motta RW (1999). "Sexually and physically abused foster care children and posttraumatic stress disorder". Journal of consulting and clinical psychology. 67 (3): 367–73. doi:10.1037/0022-006X.67.3.367. PMID 10369057. {{cite journal}}: Unknown parameter |month= ignored (help)
61. "NIMH · What are the symptoms of PTSD?". National Institute of Mental Health.
62. American Psychiatric Association (1987). Diagnostic and Statistical Manual of Mental Disorders: DSM-III-R. ISBN 0890420181.
63. American Psychiatric Association (1994). Diagnostic and statistical manual of mental disorders, quick reference. Washington, D.C.: American Psychiatric Association. p. 211. ISBN 0-89042-063-7.
64. Breslau N, Kessler RC (2001). "The stressor criterion in DSM-IV posttraumatic stress disorder: an empirical investigation". Biol. Psychiatry. 50 (9): 699–704. doi:10.1016/S0006-3223(01)01167-2. PMID 11704077.
65. Blake DD, Weathers FW, Nagy LM; et al. (1995). "The development of a Clinician-Administered PTSD Scale". J Trauma Stress. 8 (1): 75–90. doi:10.1002/jts.2490080106. PMID 7712061. {{cite journal}}: Explicit use of et al. in: |author= (help); Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
66. Foa E: The Post Traumatic Diagnostic Scale Manual. Minneapolis, NCS, 1995.
67. Brewin, C. R. et.al. (2002). Brief screening instrument for post traumatic stress disorder. British Journal of Psychiatry, 181, 158 – 162. PMID 12151288
68. Foa, E. B., Cashman, L., Jaycox, L. & Perry, K. (1997). The validation of a self-report measure of posttraumatic stress disorder : the Posttraumatic Diagnostic Scale. Psychological Assessment 9, 445–451.
69. Pietrzak RH, Southwick SM (June). "The importance of four-factor emotional numbing and dysphoria models in PTSD". Am J Psychiatry. 166 (6): 726–727. doi:10.1176/appi.ajp.2009.09010032. PMID 19487403. {{cite journal}}: Check date values in: |date= and |year= / |date= mismatch (help)
70. King DW, Leskin GA, King LA, Weathers FW (June). "Confirmatory factor analysis of the clinician-administered PTSD Scale: Evidence for the dimensionality of posttraumatic stress disorder". Psychol Assess. 10 (2): 90–96. doi:10.1037/1040-3590.10.2.90. {{cite journal}}: Check date values in: |date= and |year= / |date= mismatch (help)CS1 maint: multiple names: authors list (link)
71. Ask E, Mark S (Sep). "The structure of PTSD symptoms: A test of alternative models using confirmatory factor analysis". Br J Clin Psychol. 46 (3): 299–313. doi:10.1348/014466506X171540. PMID 17535523. {{cite journal}}: Check date values in: |date= and |year= / |date= mismatch (help)
72. Palmieri PA, Weathers FW, Difede J, King DW (May). "Confirmatory factor analysis of the PTSD Checklist and the Clinician-Administered PTSD Scale in disaster workers exposed to the World Trade Center Ground Zero". J Abnorm Psychol. 116 (2): 329–341. doi:10.1037/0021-843X.116.2.329. PMID 17516765. {{cite journal}}: Check date values in: |date= and |year= / |date= mismatch (help)CS1 maint: multiple names: authors list (link)
73. "Timeline". Retrieved 2010-04-22.
74. American Psychiatric Association (2010-03-09). "APA Modifies DSM Naming Convention to Reflect Publication Changes" (PDF). Retrieved 2010-06-11.
75. Gever, J (10 February 2010). "DSM-V Draft Promises Big Changes in Some Psychiatric Diagnoses". Retrieved 10 February 2010.
76. "309.81 Posttraumatic Stress Disorder: Proposed Revision". American Psychiatric Association. 2010. Retrieved 2010-03-20.
77. "Conditions Proposed by Outside Sources". Retrieved 11 February 2010.
78. Secretary Nicholson (2005-11-10). "No Across-the-Board Review of PTSD Cases". The Department of Veterans Affairs. {{cite news}}: |access-date= requires |url= (help); United States Department of Veteran Affairs.
79. Vedantam, Shankar (2005-12-27). "A Political Debate On Stress Disorder: As Claims Rise, VA Takes Stock". Washington Post. Retrieved 2008-03-12.
80. "Marine Corps Offers Yoga, Massages to Marriages Strained by War". Fox News. Associated Press. 2008-04-02. Retrieved 2008-04-03.
81. Dixon, Laura (February 28, 2009). "Lance Corporal Johnson Beharry accuses Government of neglecting soldiers". London: Times Online. Retrieved 2009-08-29.
82. Hickley, Matthew; Hope, Jenny (2009-03-02). "British troops in Afghanistan face mental health timebomb 'on the scale of Vietnam' | Mail Online". London: Dailymail.co.uk. Retrieved 2009-08-29.
83. "UK | Full interview: L/Cpl Johnson Beharry". BBC News. 2009-02-28. Retrieved 2009-08-29.
84. "The New Veterans Charter for CF Veterans and their Families". Vac-Acc.Gc.Ca. 2006-07-12. Retrieved 2009-08-29.
85. ^ Feldner MT, Monson CM, Friedman MJ (2007). "A critical analysis of approaches to targeted PTSD prevention: current status and theoretically derived future directions". Behav Modif. 31 (1): 80–116. doi:10.1177/0145445506295057. PMID 17179532.{{cite journal}}: CS1 maint: multiple names: authors list (link)
86. Carlier, IVE (1998). "Disaster-related post-traumatic stress in police officers: A field study of the impact of debriefing". Stress Medicine. 14 (3): 143–8. doi:10.1002/(SICI)1099-1700(199807)14:3<143::AID-SMI770>3.0.CO;2-S. {{cite journal}}: Unknown parameter |coauthors= ignored (|author= suggested) (help)
87. Mayou RA, Ehlers A, Hobbs M (2000). "Psychological debriefing for road traffic accident victims. Three-year follow-up of a randomised controlled trial". Br J Psychiatry. 176 (6): 589–93. doi:10.1192/bjp.176.6.589. PMID 10974967.{{cite journal}}: CS1 maint: multiple names: authors list (link)
88. Roberts NP, Kitchiner NJ, Kenardy J, Bisson JI (2009). "Multiple session early psychological interventions for the prevention of post-traumatic stress disorder". Issue 3. Art. No.: CD006869. DOI: 10.1002/14651858.CD006869.pub2. Cochrane Database of Systematic Reviews. Retrieved April 27, 2011.{{cite web}}: CS1 maint: multiple names: authors list (link)
89. ^ Delahanty DL (2011). "Toward the predeployment detection of risk for PTSD". American Psychiatric Assn.
90. van Zuiden M, Geuze E, Maas M, Vermetten E, Heijnen CJ, Kavelaars. "Deployment-related severe fatigue with depressive symptoms is associated with increased glucocorticoid binding to peripheral blood mono-nuclear cells". Brain Behav Immun. 23: 1132–1139.{{cite journal}}: CS1 maint: multiple names: authors list (link)
91. ^ Resnik H, Acierno R, Kilpatrick DG, Jager, N (1999). "Prevention of post-rape psychopathology: Preliminary findings of a controlled acute rape treatment study". Journal of anxiety disorders. 13: 359–370.{{cite journal}}: CS1 maint: multiple names: authors list (link)
92. Foa 1997.
93. Cahill, S. P., & Foa, E. B. (2004). A glass half empty or half full? Where we are and directions for future research in the treatment of PTSD. In S. Taylor (ed.), Advances in the Treatment of Posttraumatic Stress Disorder: Cognitive-behavioral perspectives (pp. 267-313) New York: Springer.
94. Brom D, Kleber RJ, Defares PB (1989). "Brief psychotherapy for posttraumatic stress disorders". J Consult Clin Psychol. 57 (5): 607–12. doi:10.1037/0022-006X.57.5.607. PMID 2571625. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
95. ^ Ehlers A, Bisson J, Clark DM; et al. (2010). "Do all psychological treatments really work the same in posttraumatic stress disorder?". Clin Psychol Rev. 30 (2): 269–76. doi:10.1016/j.cpr.2009.12.001. PMC 2852651. PMID 20051310. {{cite journal}}: Explicit use of et al. in: |author= (help); Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
96. Bisson JI, Ehlers A, Matthews R, Pilling S, Richards D, Turner S (2007). "Psychological treatments for chronic post-traumatic stress disorder. Systematic review and meta-analysis". The British Journal of Psychiatry : the journal of mental science. 190 (2): 97–104. doi:10.1192/bjp.bp.106.021402. PMID 17267924.{{cite journal}}: CS1 maint: multiple names: authors list (link)
97. Seidler GH, Wagner FE (2006). "Comparing the efficacy of EMDR and trauma-focused cognitive-behavioral therapy in the treatment of PTSD: a meta-analytic study". Psychol Med. 36 (11): 1515–22. doi:10.1017/S0033291706007963. PMID 16740177.
98. Hassija, C.M. & Gray, M.J. (2007). Behavioral Interventions for Trauma and Posttraumatic Stress Disorder. International Journal of Behavioral Consultation and Therapy, 3(2),166-175. BAO
99. Mulick, P.S., Landes, S. & Kanter, J.W. (2005) Contextual Behavior Therapies in the Treatment of PTSD: A Review. International Journal of Behavioral Consultation and Therapy, 1(3), 223-228
100. Hassija, C.M. & Gray, M.J. (2007). Behavioral Interventions for Trauma and Posttraumatic Stress Disorder. International Journal of Behavioral Consultation and Therapy, 3(2), 166-175.
101. Mulick, P.S., and Naugle, A.E. (2009). Behavioral Activation in the Treatment of Comorbid Posttraumatic Stress Disorder and Major Depressive Disorder. International Journal of Behavioral Consultation and Therapy, 5(2), 330-339.
102. Grohol, JM. "What is Exposure Therapy?". Retrieved 2010-07-14.
103. Joseph, JS (2008). BAO "Exposure Therapy for Posttraumatic Stress Disorder". Journal of Behavior Analysis of Offender and Victim: Treatment and Prevention. 1 (4): 69–80. Retrieved 2010-05-10. {{cite journal}}: Check |url= value (help); Unknown parameter |coauthors= ignored (|author= suggested) (help)
104. Ursano RJ, Bell C, Eth S; et al. (2004). "Practice guideline for the treatment of patients with acute stress disorder and posttraumatic stress disorder". Am J Psychiatry. 161 (11 Suppl): 3–31. PMID 15617511. {{cite journal}}: Explicit use of et al. in: |author= (help); Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
105. Committee on Treatment of Posttraumatic Stress Disorder, Institute of Medicine: Treatment of Posttraumatic Stress Disorder: An Assessment of the Evidence. Washington, D.C.: National Academies Press, 2008 ISBN 0-309-10926-4.
106. "Prolonged Exposure Therapy". 2009-09-29. Retrieved 2010-07-14.
107. Karlin B. E., Ruzek J. I. Chard, Eftekhari A., Monson C. M., Hembree E. A., Resick P. A., Foa E. B. (2010). "Dissemination of evidence-based psychological treatments for posttraumatic stress disorder in the Veterans Health Administration". Journal of Traumatic Stress. 23 (6): 663–673. doi:10.1002/jts.20588. PMID 21171126.{{cite journal}}: CS1 maint: multiple names: authors list (link)
108. Devilly GJ & Spence SH (1999). "The relative efficacy and treatment distress of EMDR and a cognitive-behavior trauma treatment protocol in the amelioration of posttraumatic stress disorder". J Anxiety Disord. 13 (1–2): 131–57. doi:10.1016/S0887-6185(98)00044-9. PMID 10225505.
109. "Practice Guideline for the treatment of patients with acute stress disorder and posttraumatic stress disorder". Arlington, VA: American Psychiatric Association. 2004.
110. VA/DoD clinical practice guideline for the management of post-traumatic stress. Washington, DC: Department of Veteran Affairs & United States Department of Defense. June 2008. Archived from the original on 2008-06-29. {{cite book}}: Check date values in: |year= / |date= mismatch (help)
111. See
     • Australian guidelines for the treatment of adults with acute stress disorder and post traumatic stress disorder. Melbourne, Victoria: ACPTMH. 2007. ISBN 9780975224663.
     • "Post traumatic stress disorder (PTSD): The management of adults and children in primary and secondary care". London: National Institute for Health and Clinical Excellence. 2005.
     • Dutch National Steering Committee Guidelines Mental Health and Care. Guidelines for the diagnosis treatment and management of adult clients with an anxiety disorder. Utrecht, Netherlands: The Dutch Institute for Healthcare Improvement (CBO).
     • Foa, EB; Keane, TM; Friedman, MJ (2000). Effective treatments for PTSD: Practice guidelines of the International Society for Traumatic Stress Studies. New York: Guilford Press. ISBN 1606230018.
     • Bleich, A; Kolter, M; Kutz, E; Shaley, A (2002). Guidelines for the assessment and professional intervention with terror victims in the hospital and the community. Jerusalem, Israel: Israeli National Council for Mental Health.
     • United Kingdom Department of Health (2001). Treatment choice in psychological therapies and counseling evidence based on clinical practice guideline. London.{{cite book}}: CS1 maint: location missing publisher (link)
112. Australian guidelines for the treatment of adults with acute stress disorder and post traumatic stress disorder. Melbourne, Victoria: Australian Centre for Posttraumatic Mental Health. 2007. ISBN 9780975224663.
113. Weissman MM, Markowitz JC, Klerman GL: Clinician’s Quick Guide to Interpersonal Psychotherapy. New York: Oxford University Press, 2007.
114. Bleiberg KL, Markowitz JC (2005). "A pilot study of interpersonal psychotherapy for posttraumatic stress disorder". Am J Psychiatry. 162 (1): 181–3. doi:10.1176/appi.ajp.162.1.181. PMID 15625219. {{cite journal}}: Unknown parameter |month= ignored (help)
115. http://www.columbiatrauma.org/
116. Markowitz JC, Milrod B, Bleiberg K, Marshall RD: Interpersonal factors in understanding and treating posttraumatic stress disorder. J Psychiatr Pract. 2009 Mar;15(2):133-40. PMID: 19339847
117. Markowitz JC: IPT and PTSD. Depress Anxiety. 2010 Oct;27(10):879-81.
118. Maxmen, J. S.; Ward, N. G. (1995). Essential psychopathology and its treatment, 2nd ed., revised for DSM-IV (second ed.). New York: W. W. Norton. p. 280. ISBN 0-393-70173-5.
119. ^ Maxmen, J. S.; Ward, N. G. (2002). Psychotropic drugs: fast facts (third ed.). New York: W. W. Norton. p. 346. ISBN 0-393-70301-0.
120. ^ Berger, W.; Mendlowicz, MV.; Marques-Portella, C.; Kinrys, G.; Fontenelle, LF.; Marmar, CR.; Figueira, I. (2009). "Pharmacologic alternatives to antidepressants in posttraumatic stress disorder: a systematic review". Prog Neuropsychopharmacol Biol Psychiatry. 33 (2): 169–80. doi:10.1016/j.pnpbp.2008.12.004. PMC 2720612. PMID 19141307. {{cite journal}}: Unknown parameter |month= ignored (help)
121. Cooper, J.; Carty, J.; Creamer, M. (2005). "Pharmacotherapy for posttraumatic stress disorder: empirical review and clinical recommendations". Aust N Z J Psychiatry. 39 (8): 674–82. doi:10.1111/j.1440-1614.2005.01651.x. PMID 16050921. {{cite journal}}: Unknown parameter |month= ignored (help)
122. Yehuda R (2000). "Biology of posttraumatic stress disorder". J Clin Psychiatry. 61 (Suppl 7): 14–21. PMID 10795605.
123. ^ Maxmen, J. S.; Ward, N. G. (2002). Psychotropic drugs: fast facts (third ed.). New York: W. W. Norton. p. 347. ISBN 0-393-70301-0.
124. Marshall RD, Beebe KL, Oldham M, Zaninelli R (2001). "Efficacy and safety of paroxetine treatment for chronic PTSD: a fixed-dose, placebo-controlled study". Am J Psychiatry. 158 (12): 1982–8. doi:10.1176/appi.ajp.158.12.1982. PMID 11729013. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
125. Brady K, Pearlstein T, Asnis GM; et al. (2000). "Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial". JAMA. 283 (14): 1837–44. doi:10.1001/jama.283.14.1837. PMID 10770145. {{cite journal}}: Explicit use of et al. in: |author= (help); Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
126. Davidson JR, Rothbaum BO, van der Kolk BA, Sikes CR, Farfel GM (2001). "Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder". Arch Gen Psychiatry. 58 (5): 485–92. doi:10.1001/archpsyc.58.5.485. PMID 11343529. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
127. Maxmen, J. S.; Ward, N. G. (1995). Essential psychopathology and its treatment, 2nd ed., revised for DSM-IV (second ed.). New York: W. W. Norton. p. 104. ISBN 0-393-70173-5.
128. Maxmen, J. S.; Ward, N. G. (1995). Essential psychopathology and its treatment, 2nd ed., revised for DSM-IV (second ed.). New York: W. W. Norton. p. 175. ISBN 0-393-70173-5.
129. ^ Maxmen, J. S.; Ward, N. G. (2002). Psychotropic drugs: fast facts (third ed.). New York: W. W. Norton. p. 348. ISBN 0-393-70301-0.
130. ^ Maxmen, J. S.; Ward, N. G. (2002). Psychotropic drugs: fast facts (third ed.). New York: W. W. Norton. p. 349. ISBN 0-393-70301-0.
131. ^ Lacy CF, Armstrong LL; et al. (2008). Drug Information Handbook. Lexi-Comp. pp. 260, 934. {{cite book}}: Explicit use of et al. in: |author= (help)
132. "Lamotrigine FAQ". Retrieved 2007-05-01.
133. SSRIs versus Non-SSRIs in Post-traumatic Stress Disorder, Department of Psychiatry and Behavioral Sciences, Montefiore Medical Center, Albert Einstein College of Medicine.
134. Hertzberg MA, Butterfield MI, Feldman ME; et al. (1999). "A preliminary study of lamotrigine for the treatment of posttraumatic stress disorder". Biol. Psychiatry. 45 (9): 1226–9. doi:10.1016/S0006-3223(99)00011-6. PMID 10331117. {{cite journal}}: Explicit use of et al. in: |author= (help); Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
135. ^ Kapfhammer, HP. (2008). "". Psychiatr Danub. 20 (4): 532–45. PMID 19011595. {{cite journal}}: Unknown parameter |month= ignored (help)
136. Maxmen, J. S.; Ward, N. G. (1995). Essential psychopathology and its treatment, 2nd ed., revised for DSM-IV (second ed.). New York: W. W. Norton. p. 95. ISBN 0-393-70173-5.
137. ^ Pitman RK, Sanders KM, Zusman RM; et al. (2002). "Pilot study of secondary prevention of posttraumatic stress disorder with propranolol". Biol. Psychiatry. 51 (2): 189–92. doi:10.1016/S0006-3223(01)01279-3. PMID 11822998. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
138. ^ Reist, C (2005). Post-traumatic Stress Disorder. Compendia, Build ID: F000005, published by Epocrates.com
139. Martényi, F. (2005). "". Neuropsychopharmacol Hung. 7 (1): 11–21. PMID 16167463. {{cite journal}}: Unknown parameter |month= ignored (help)
140. Cohen H, Matar MA, Buskila D, Kaplan Z, Zohar J. (2008). "Early post-stressor intervention with high-dose corticosterone attenuates posttraumatic stress response in an animal model of posttraumatic stress disorder". Biol Psychiatry. 64 (8): 708–717. doi:10.1016/j.biopsych.2008.05.025. PMID 18635156.{{cite journal}}: CS1 maint: multiple names: authors list (link)
141. Sapolsky RM, Romero LM, Munck AU. (2000). "How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions". Endocr Review. 21 (1): 55–89. doi:10.1210/er.21.1.55. PMID 10696570.{{cite journal}}: CS1 maint: multiple names: authors list (link)
142. "Study of 3,4-Methylenedioxymethamphetamine-Assisted Psychotherapy in People With Posttraumatic Stress Disorder". ClinicalTrials.gov. U.S. National Institutes of Health. 2009. {{cite web}}: Unknown parameter |month= ignored (help) Retrieved on June 17, 2009.
143. "Randomized Placebo-Controlled Study of MDMA-Assisted Psychotherapy in People With PTSD - Israel". ClinicalTrials.gov. U.S. National Institutes of Health. 2009. {{cite web}}: Unknown parameter |month= ignored (help) Retrieved on June 17, 2009.
144. {Khoshnu, E (October 2006). "Clonidine for Treatment of PTSD". Clinical Psychiatry News. 34 (10): 22. Retrieved 9 February 2010.
145. Schelling G, Roozendaal B, Krauseneck T, Schmoelz M, DE Quervain D, Briegel J. (2006). "Efficacy of hydrocortisone in preventing posttraumatic stress disorder following critical illness and major surgery". Ann N Y Acad Sci. 1071 (1): 46–53. doi:10.1196/annals.1364.005. PMID 16891561.{{cite journal}}: CS1 maint: multiple names: authors list (link)
146. Weis F, Kilger E, Roozendaal B, de Quervain DJ, Lamm P, Schmidt M, Schmölz M, Briegel J, Schelling G. (2006). "Stress doses of hydrocortisone reduce chronic stress symptoms and improve health-related quality of life in high-risk patients after cardiac surgery: a randomized study". J Thorac Cardiovasc Surg. 131 (2): 277–282. doi:10.1016/j.jtcvs.2005.07.063. PMID 16434254.{{cite journal}}: CS1 maint: multiple names: authors list (link)
147. Schelling G, Kilger E, Roozendaal B, de Quervain DJ, Briegel J, Dagge A, Rothenhäusler HB, Krauseneck T, Nollert G, Kapfhammer HP. (2004). "Stress doses of hydrocortisone, traumatic memories, and symptoms of posttraumatic stress disorder in patients after cardiac surgery: a randomized study". Biol Psychiatry. 55 (6): 627–633. doi:10.1016/j.biopsych.2003.09.014. PMID 15013832.{{cite journal}}: CS1 maint: multiple names: authors list (link)
148. Holbrook, T.L.; Galarneau, MR; Dye, JL; Quinn, K; Dougherty, AL; et al. (2010-01-14). "Morphine use after combat injury in Iraq and post-traumatic stress disorder". N Engl J Med. 362 (110): 110–7. doi:10.1056/NEJMoa0903326. PMID 20071700. Retrieved 2009-02-05. {{cite journal}}: Explicit use of et al. in: |first= (help)
149. ^ Maxmen, J. S.; Ward, N. G. (2002). Psychotropic drugs: fast facts (third ed.). New York: W. W. Norton. pp. 347–349. ISBN 0-393-70301-0.
150. ^ Cohen SI (1995). "Alcohol and benzodiazepines generate anxiety, panic and phobias". J R Soc Med. 88 (2): 73–77. PMC 1295099. PMID 7769598. {{cite journal}}: Unknown parameter |month= ignored (help)
151. Spates, R. & Souza (2007). Treatment of PTSD and Substance Abuse Comorbidity. The Behavior Analyst Today, 9(1), 11-26
152. "Mortality and Burden of Disease Estimates for WHO Member States in 2004". World Health Organization.
153. ^ List of countries by population
154. ^ "Mortality and Burden of Disease Estimates for WHO Member States: Persons, all ages (2004)" (xls). World Health Organization. 2004. Retrieved 2009-11-12.
155. ^ "Mortality and Burden of Disease Estimates for WHO Member States: Females, all ages (2004)" (xls). World Health Organization. 2004. Retrieved 2009-11-12.
156. ^ "Mortality and Burden of Disease Estimates for WHO Member States: Males, all ages (2004)" (xls). World Health Organization. 2004. Retrieved 2009-11-12.
157. The War's Costs . Digital History.
158. Bradshaw, G.A. (no date). "Post-Traumatic Stress and Elephants in Captivity" (PDF). Retrieved 2010-01-01. {{cite web}}: Check date values in: |date= (help); Unknown parameter |coauthors= ignored (|author= suggested) (help)
159. Bradshaw, G.A. (2005-02-24). "Elephant breakdown" (PDF). Nature. 423. doi:10.1038/433807a. Retrieved 2010-01-01. {{cite journal}}: Unknown parameter |coauthors= ignored (|author= suggested) (help)
160. Associated Press (2010-08-03). "PTSD Victims Include Military Dogs, Too". CBS News.
161. ^ When trauma tips you over: PTSD Part 1 All in the Mind, Australian Broadcasting Commission, 9 October 2004.
162. Swartz' Textbook of Physical Diagnosis: History and Examination.
163. MSG. I. S. Parrish, USA Retired (2008). "Ch. 1, Section II. HISTORY". Military Veterans PTSD Reference Manual (Revised ed.). Bryn Mawr, PA: Infinity Publishing. pp. 01–03. ISBN 0-7414-0077-4. {{cite book}}: |access-date= requires |url= (help); External link in |chapterurl= (help); Unknown parameter |chapterurl= ignored (|chapter-url= suggested) (help); Unknown parameter |month= ignored (help)
164. World War One – A New Kind of War | Part II, From 14 - 18 Understanding the Great War, by Stéphane Audoin-Rouzeau, Annette Becker
165. ^ Shalev, Arieh Y.; Yehuda, Rachel; Alexander C. McFarlane (2000). International handbook of human response to trauma. New York: Kluwer Academic/Plenum Press. ISBN 0-306-46095-5.{{cite book}}: CS1 maint: multiple names: authors list (link); on-line.

External links

• Template:DMOZ
• Template:DMOZ
• Management of PTSD in adults and children by the National Institute for Health and Clinical Excellence (UK)
• Practice guidelines from the American Psychiatric Association
• Post Traumatic Stress Disorder Information Resource from The University of Queensland School of Medicine
• Resources for Parents of Children with PTSD from The Children's Hospital of Philadelphia

• Abnormal psychology
• Alcohol abuse
• Anxiety disorders
• Counseling
• Homelessness
• Military medicine
• Military personnel
• Military psychiatry
• Military sociology
• Military veterans' affairs
• Mood disorders
• Neurotic, stress-related and somatoform disorders
• Rape
• Stress
• Traumatology